Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.36
+0.14 (2.68%)
At close: Dec 5, 2025, 4:00 PM EST
5.33
-0.03 (-0.56%)
After-hours: Dec 5, 2025, 4:10 PM EST
Generation Bio Co. Revenue
Generation Bio Co. had revenue of $1.59M in the quarter ending September 30, 2025, a decrease of -78.90%. This brings the company's revenue in the last twelve months to $15.27M, down -17.82% year-over-year. In the year 2024, Generation Bio Co. had annual revenue of $19.89M with 236.92% growth.
Revenue (ttm)
$15.27M
Revenue Growth
-17.82%
P/S Ratio
2.34
Revenue / Employee
$132,783
Employees
115
Market Cap
36.12M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GBIO News
- 4 weeks ago - Generation Bio Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Generation Bio Announces CEO Transition - GlobeNewsWire
- 4 months ago - Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Generation Bio Announces 1-for-10 Reverse Stock Split - GlobeNewsWire
- 5 months ago - Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 months ago - Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 months ago - Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results - GlobeNewsWire
- 8 months ago - Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - GlobeNewsWire